Abstract:Lipoxins (LXs) display unique pro-resolving and anti-inflammatory functions in a variety of inflammatory conditions. The present study was undertaken to investigate the effects of BML-111 (5(S),6(R),7-trihydroxyheptanoic acid methyl ester), the agonist of lipoxin A₄ receptor, in a model of Lipopolysaccharides (LPS) and d-Galactosamine (d-GalN) induced acute liver injury, and to explore the mechanisms. Histopathological analyses were carried out to quantify liver injury degree. The activities of myeloperoxidase (MPO) were examined to evaluate the levels of neutrophil infiltration. The activities of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) in serum were detected to evaluate the functions of the liver. The amounts of tumor necrosis factor-α (TNF-α), interleukin-10 (IL-10), and interleukin-1β (IL-1β) were measured using enzyme-linked immunosorbent assay (ELISA), and the expression levels of transforming growth factor-β1(TGF-β1) and cyclooxygenase-2 (COX-2) were examined using Western blotting. The antioxidant capacity, the activities of inducible nitric oxide synthase (iNOS), the contents of malondialdehyde (MDA) and nitric oxide (NO) were analyzed with the kits via biochemical analysis. We established the model of acute liver injury with lipopolysaccharide and d-Galactosamine (LPS/d-GalN): (1) histopathological results and MPO activities, with the activities of AST and ALT in serum, consistently demonstrated LPS and d-GalN challenge could cause severe liver damage, but BML-111 could prevent pathological changes, inhibit neutrophil infiltration, and improve the hepatic function; (2) LPS/d-GalN increased TNF-α, IL-1β, COX-2, and IL-10, while decreasing TGF-β1. However, BML-111 could repress LPS/d-GalN -induced TNF-α, IL-1β and COX-2, meanwhile increasing the expression levels of TGF-β1 and IL-10; (3) LPS/d-GalN inhibited the activities of superoxide dismutase (SOD), catalase (CAT), total antioxidant capacity (T-AOC), and hydroxyl radical-scavenging ability, simultaneously increasing the levels of MDA and NO, so also the activity of iNOS. Otherwise, BML-111 could reverse all the phenomena. In a word, BML-111 played a protective role in acute liver injury induced by LPS and d-GalN in rats, through improving antioxidant capacity and regulating the balance of inflammatory cytokines.

BML-111, a lipoxin receptor agonist, protects against acute injury via regulating the renin angiotensin-aldosterone system.

BML-111 Protected LPS/D-GalN-Induced Acute Liver Injury in Rats.

BML-111 Equilibrated ACE-AngII-AT1R and ACE2-Ang-(1-7)-Mas Axis to Protect Hepatic Fibrosis in Rats.

Protective Effects of Bml-111, A Lipoxin A(4) Receptor Agonist, on Carbon Tetrachloride-Induced Liver Injury in Mice

Lipoxin A4attenuates LPS-induced Acute Lung Injury Via Activation of the ACE2-Ang-(1-7)-Mas Axis

BML-111 Attenuates Hemorrhagic Shock-Induced Acute Lung Injury Through Inhibiting Activation of Mitogen-Activated Protein Kinase Pathway in Rats.

BML-111, a Lipoxin Receptor Agonist, Protects Haemorrhagic Shock-Induced Acute Lung Injury in Rats.

BML-111 Attenuates Acute Lung Injury in Endotoxemic Mice.

BML-11, A Lipoxin Receptor Agonist, Protected Carbon Tetrachloride-Induced Hepatic Fibrosis in Rats

BML-111 ameliorates endotoxin-induced liver injury through increasing prostaglandin J 2 production via ERK / COX 2 pathway

Effect of BML-111 on Acute Lung Injury Induced by Hemorrhagic Shock and Resuscitation in Rats

BML-111, a Lipoxin Receptor Agonist, Ameliorates ‘Two-Hit’-induced Acute Pancreatitis-Associated Lung Injury in Mice by the Upregulation of Heme Oxygenase-1

BML-111, a Lipoxin Receptor Agonist, Modulates the Immune Response and Reduces the Severity of Collagen-Induced Arthritis.

Lipoxin Receptor Agonist, May Be a Potential Treatment for Hemorrhagic Shock-Induced Acute Lung Injury

BML-111 alleviates inflammatory response of alveolar epithelial cells via miR-494/Slit2/Robo4 signalling axis to improve acute lung injury

Effect of BML-111 on NF-κB Pathway During Acute Lung Injury Induced by Hemorrhagic Shock and Resuscitation in Rats

BML-111, a Lipoxin Receptor Agonist, Attenuates Ventilator-Induced Lung Injury in Rats

Effects of ambroxol on nuclear factor-kappa B signaling transduction in lipopolysaccaride-induced acute lung injury in rats

Lipoxin A4 Ameliorates Cerebral Ischaemia/reperfusion Injury Through Upregulation of Nuclear Factor Erythroid 2-Related Factor 2.

Lipoxin A4 attenuates LPS-induced mouse acute lung injury via Nrf2-mediated E-cadherin expression in airway epithelial cells

Aspirin-triggered Lipoxin A4 Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Inhibiting Activation of Mitogen-Activated Protein Kinases and NF-κB in Mice.